Table 2.
Baseline Characteristics of the Study Population
| SWSD |
OSA |
Narcolepsy |
||||
|---|---|---|---|---|---|---|
| Modafinil | PL | Modafinil | PL | Modafinil | PL | |
| Age, ya | 39.2 (9.4) | 39.3 (9.0) | 48.7 (9.2) | 50.6 (9.6) | 42.0 (13.4) | 41.3 (13.2) |
| Menb | 145 (53) | 105 (54) | 229 (78) | 139 (74) | 168 (46) | 85 (46) |
| Raceb | ||||||
| White | 196 (72) | 132 (68) | 257 (88) | 166 (88) | 301 (82) | 154 (83) |
| Other | 77 (28) | 62 (32) | 35 (12) | 22 (12) | 68 (18) | 31 (17) |
| BMI, kg/m2a | 30.2 (6.7) | 30.8 (6.3) | 36.1 (7.6) | 36.2 (8.0) | 28.9 (6.4) | 28.3 (6.1) |
| Combined | Modafinil |
PL | ||||
| 200 mg | 300 mg | 400 mg | All | |||
| Age, ya | 41.7 (11.7) | 40.2 (9.7) | 46.1 (11.8) | 43.3 (11.8) | 43.7 (11.8) | |
| Menb | 277 (58) | 43 (48) | 222 (60) | 542 (58) | 329 (58) | |
| Raceb | ||||||
| White | 374 (78) | 67 (74) | 313 (85) | 754 (81) | 452 (80) | |
| Other | 103 (22) | 23 (26) | 54 (15) | 180 (19) | 115 (20) | |
| BMI, kg/m2a | 31.3 (7.6) | 29.8 (6.6) | 32.7 (7.9) | 31.7 (7.7) | 32.0 (7.9) | |
a
Data are presented as mean (SD).
b
Data are presented as number (%).
BMI refers to body mass index; OSA, obstructive sleep apnea; PL, placebo; SWSD, shift work sleep disorder.